https://sputniknews.in/20221223/indian-govt-approves-first-nasal-vaccine-against-covid-19-201188.html
Indian Gov’t Approves First Nasal Vaccine Against COVID-19
Indian Gov’t Approves First Nasal Vaccine Against COVID-19
Sputnik India
The Indian government has approved new nasal vaccine for Covid-19 prevention as a heterologous booster and will be available in private hospitals, local media reports.
2022-12-23T13:21+0530
2022-12-23T13:21+0530
2022-12-23T13:22+0530
political affairs
vaccination
covid-19
india
health
https://cdn1.img.sputniknews.in/img/07e6/0c/17/203188_0:402:2925:2047_1920x0_80_0_0_d0faea7f2c570ea6a6208d3734cfaa39.jpg
The Indian government on Friday approved a new nasal vaccine against COVID-19 developed by Bharat Biotech.The vaccine will be used as a heterologous booster for COVID-19 prevention and will be first available in private hospitals, local media reports say.India first introduced a COVID-19 vaccine -- Oxford-AstraZeneca -- in January last year. It was manufactured under the license by the Serum Institute of India (SII) under the trade name Covishield. At the same time, Covaxin developed by Bharat Biotech was also approved. Among other vaccines used in India there are Spikevax, manufactured by the US company Moderna and approved in India in June, 2021, the Johnson & Johnson vaccine Jcovden, approved in August, 2021, and Zydus Cadila ZyCoV-D, approved in July, 2021.
https://sputniknews.in/20221222/india-to-reintroduce-covid-19-curbs-amid-rising-cases-globally-193658.html
india
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2022
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
oxford-astrazeneca vaccine, astrazeneca vaccine, covid-19 vaccination in india, sputnik v vaccine, nasal vaccine against covid-19, bharat biotech
oxford-astrazeneca vaccine, astrazeneca vaccine, covid-19 vaccination in india, sputnik v vaccine, nasal vaccine against covid-19, bharat biotech
Indian Gov’t Approves First Nasal Vaccine Against COVID-19
13:21 23.12.2022 (Updated: 13:22 23.12.2022) Reports say the new vaccine will be included in the coronavirus vaccination program starting from Friday already.
The Indian government on Friday approved a new nasal vaccine against COVID-19 developed by Bharat Biotech.
The vaccine will be used as a heterologous booster for COVID-19 prevention and will be first available in private hospitals, local media reports say.
India first introduced a COVID-19 vaccine -- Oxford-AstraZeneca -- in January last year.
It was manufactured under the license by the Serum Institute of India (SII) under the trade name Covishield. At the same time, Covaxin developed by Bharat Biotech was also approved.
In April last year India also approved Sputnik V developed by Russia’s Gamaleya Institute after a month earlier, the Russian Direct Investment Fund (RDIF) and India’s pharmaceutical company Dr. Reddy’s Laboratories signed an agreement for the production of 100 million doses of Sputnik V.
Among other vaccines used in India there are Spikevax, manufactured by the US company Moderna and approved in India in June, 2021, the Johnson & Johnson vaccine Jcovden, approved in August, 2021, and Zydus Cadila ZyCoV-D, approved in July, 2021.
